Opioid overdose prevention education in Texas during the COVID-19 pandemic. 2023

Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, MC 7793, San Antonio, TX, 78229, USA. Mathias@uthscsa.edu.

Distribution of naloxone and training on its proper use are evidence-based strategies for preventing opioid overdose deaths. In-person naloxone training was conducted in major metropolitan areas and urban centers across Texas as part of a state-wide targeted opioid response program. The training program transitioned to a live, virtual format during the COVID-19 public health emergency declaration. This manuscript describes the impact of this transition through analyses of the characteristics of communities reached using the new virtual training format. Training participant addresses were compared to county rates of opioid overdose deaths and broadband internet access, and census block comparison to health services shortages, rural designation, and race/ethnicity community characteristics. The virtual training format reached more learners than the in-person events. Training reached nearly half of the counties in Texas, including all with recent opioid overdose deaths. Most participants lived in communities with a shortage of health service providers, and training reached rural areas, those with limited broadband internet availability, and majority Hispanic communities. In the context of restrictions on in-person gathering, the training program successfully shifted to a live, online format. This transition increased participation above rates observed pre-pandemic and reached communities with the need for equipping those most likely to witness an opioid overdose with the proper use of naloxone.

UI MeSH Term Description Entries
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000083682 Opiate Overdose Accidental or deliberate use of an OPIOID in excess of normal dosage. It includes overdose for prescription and illicit opioids. Opioid Overdose,Opiate Overdoses,Opioid Overdoses,Overdose, Opiate,Overdose, Opioid
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid
D013781 Texas State bounded on the north by Oklahoma, on the east by Arkansas and Louisiana, on the south by Mexico, and on the west by New Mexico.
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic
D062787 Drug Overdose Accidental or deliberate use of a medication or street drug in excess of normal dosage. Drug Overdoses,Overdose, Drug,Overdoses, Drug

Related Publications

Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
August 2021, Harm reduction journal,
Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
January 2023, Health & place,
Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
October 2022, International journal of environmental research and public health,
Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
January 2023, Journal of opioid management,
Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
April 2024, International journal of environmental research and public health,
Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
December 2022, Annals of medicine,
Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
January 2022, Substance abuse,
Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
December 2020, Journal of urban health : bulletin of the New York Academy of Medicine,
Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
January 2022, Journal of addiction medicine,
Charles W Mathias, and Diana M Cavazos, and Kelly McGlothen-Bell, and Allison D Crawford, and Brieanna Flowers-Joseph, and Zhan Wang, and Lisa M Cleveland
November 2022, Journal of the American Geriatrics Society,
Copied contents to your clipboard!